ACC.20/WCC Presentation Slides | Evinacumab Significantly Reduces LDL-C
Description:
ACC.20/WCC Presentation Slides | Evinacumab Significantly Reduces LDL-C in Patients With Homozygous FH
Date: March 30, 2020
Clinical Topics: Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Lipid Metabolism, Nonstatins, Acute Heart Failure
Keywords: ACC Scientific Session Newspaper, acc20slides, Cholesterol, LDL, Dyslipidemias, Primary Prevention, Metabolic Syndrome, Heart Failure